Zhang Wan-Rong, Lang Na
Zhongguo Zhen Jiu. 2014 Dec;34(12):1185-8.
To explore the clinical efficacy and effect mechanism on chronic urticaria treated with moving cupping therapy combined with autohemotherapy with acupaint injection for desensitization at acupoints.
One hundred and four patients of chronic urticaria were randomized into a comprehensive therapy group and a medication group, 52 cases in each one. In the comprehensive therapy group, the moving cupping therapy along the governor vessel and bladder meridian of foot-taiyang was applied combined with autohemotherapy with acupaint injection for desensitization at acupoints. The self-venous blood was injected at bilateral Quchi (LI 11) and Zusanli (ST 36), 1 mL at each acupoint, once every 3 days. In the medication group, cetirizine tablets, 10 mg were prescribed for oral administration, once every day, and the compound dexamethasone acetate cream was used externally, once to twice a day. The clinical efficacy: was observed in 30 days of treatment in the two groups. The changes of serum interleukin 4 (IL-4) and immunoglobulin E (Ig E) before and after treatment were observed. The recurrence rate was compared between the two groups in 3 months after treatment.
The cured and markedly effective rate was 90.4% (47/52) in the comprehensive therapy group, which was higher obviously than 78.8% (41/52, P < 0.05) in the medication group. The levels of serum IL-4 and IgE were reduced in the patients of the two groups, indicating the significant difference in comparison before and after treatment (all P < 0.01) and the reducing degree in the comprehensive therapy group was much more significant than that in the medicine group (both P < 0.01). The recurrence rate was 19. 1% (9/47) in the comprehensive therapy group in the 3-month follow-up after treatment, and apparently lower than 51.2% (21/41, P < 0.01).
The moving cupping therapy combined with autohemotherapy with acupaint injection for desensitization at acupoints achieves the better efficacy on chronic urticaria compared with the routine western medicine treatment and the recurrence rate is low. The effect mechanism is possibly related to the down-regulation of serum IL-4 and IgE in the patients.
探讨走罐疗法联合穴位注射自血脱敏疗法治疗慢性荨麻疹的临床疗效及作用机制。
将104例慢性荨麻疹患者随机分为综合治疗组和药物治疗组,每组52例。综合治疗组采用沿督脉及足太阳膀胱经走罐疗法联合穴位注射自血脱敏疗法,于双侧曲池(LI 11)、足三里(ST 36)注射自身静脉血,每穴1 mL,每3天1次。药物治疗组口服西替利嗪片10 mg,每日1次,外用复方醋酸地塞米松乳膏,每日1~2次。观察两组治疗30天的临床疗效,观察治疗前后血清白细胞介素4(IL-4)和免疫球蛋白E(IgE)的变化,比较两组治疗后3个月的复发率。
综合治疗组痊愈显效率为90.4%(47/52),明显高于药物治疗组的78.8%(41/52,P<0.05)。两组患者血清IL-4和IgE水平均降低,治疗前后比较差异有统计学意义(均P<0.01),且综合治疗组降低程度明显大于药物治疗组(均P<0.01)。综合治疗组治疗后3个月随访复发率为19.1%(9/47),明显低于药物治疗组的51.2%(21/41,P<0.01)。
走罐疗法联合穴位注射自血脱敏疗法治疗慢性荨麻疹较常规西药治疗疗效更好,复发率低,其作用机制可能与降低患者血清IL-4和IgE水平有关。